Your institution may have access to this item. Find your institution then sign in to continue.
Title
THERAVECTYS SA v. IMMUNE DESIGN CORP.
Abstract
The article discusses the U.S. court case Theravectys SA v. Immune Design Corp. It mentions that as per the case, plaintiff Theravectys SA (TVS) and defendant Immune Design Corp. (IDC) were two biotechnology companies, which conducted clinical trials of lentiviral vector vaccines in humans. It reveals that TVS asserted claims of tortious interference with contractual relations and misappropriation of trade secrets against IDC.